NLRP3 and hepatocellular carcinoma: In line with this, the NLRP3 inflammasome pathway has been described to have a procarcinogenic effect in hep3B cells, in which tumor-suppressive miR-223 promotes apoptosis and inhibits the proliferation of HCC cells by negatively regulating NLRP3 and downstream cytokines [122].